U.S. Renewable Energy Stock News

NYSE:CHH
NYSE:CHHHospitality

How Ascend’s 500-Property Milestone And China Master Franchise At Choice Hotels (CHH) Has Changed Its Investment Story

In March 2026, Choice Hotels International’s Ascend Hotel Collection passed the 500-property mark, adding new U.S. locations such as The Harrison Hotel in Downtown Hollywood, Florida and The Gould Hotel in Seneca Falls, New York. This expansion is underpinned by a 70-hotel pipeline and fresh international moves into Poland, Chile, Kenya’s Maasai Mara, and a master franchise deal in China adding over 9,500 rooms to the brand. We’ll now examine how Ascend’s 500-property scale and China master...
NYSE:ZBH
NYSE:ZBHMedical Equipment

A Look At Zimmer Biomet (ZBH) Valuation After Revenue Beat EPS Miss And Acquisition Progress

Zimmer Biomet Holdings (ZBH) drew fresh attention after reporting 10.9% year-on-year revenue growth that came in 0.9% above analyst expectations, while slightly missing full-year EPS guidance despite progress on EPS, free cash flow, and acquisitions. See our latest analysis for Zimmer Biomet Holdings. The latest earnings update landed against a weak share price backdrop, with a 30 day share price return showing an 11% decline and a 1 year total shareholder return showing a 19.86% decline...
NasdaqGS:PTC
NasdaqGS:PTCSoftware

Assessing PTC (PTC) Valuation After Recent Weak Share Price Performance

Event context and recent price performance PTC (PTC) shares recently closed at US$149.81, with the stock showing a 0.6% decline over the past day and a 3.9% decline over the past week. This sets the backdrop for investors assessing current levels. See our latest analysis for PTC. While the recent share price return has been weak, with a 16.3% decline over 90 days and an 11.9% decline year to date, the 3 year total shareholder return of 23.1% and 5 year total shareholder return of 10.6% show a...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

Why Protagonist Therapeutics (PTGX) Is Up 7.0% After First FDA Approval For ICOTYDE Psoriasis Drug

Protagonist Therapeutics recently held a special call to discuss the U.S. FDA approval of ICOTYDE (icotrokinra) for the treatment of moderate to severe plaque psoriasis, marking a major regulatory milestone for the company. This approval highlights the company’s ability to successfully advance a novel therapeutic into the market for a serious, chronic skin condition with significant unmet patient needs. We’ll now explore how the FDA approval of ICOTYDE for moderate to severe plaque psoriasis...
NYSE:FCPT
NYSE:FCPTSpecialized REITs

A Look At Four Corners Property Trust (FCPT) Valuation After Recent Share Price Weakness

Four Corners Property Trust (FCPT) is back on investor radars after recent share price moves, with the stock last closing at US$24.26 and showing mixed returns over the past year and past 3 months. See our latest analysis for Four Corners Property Trust. Recent trading has been softer, with a 1-day share price return of 4.0% decline and a 7-day share price return of 5.4% decline, while the 1-year total shareholder return of 8.7% decline contrasts with positive 3 and 5 year total shareholder...
NasdaqGS:VC
NasdaqGS:VCAuto Components

A Look At Visteon (VC) Valuation After New NVIDIA AI Arbitration Platform Announcement

Visteon (VC) is back in focus after announcing an edge-to-cloud AI arbitration platform for software-defined vehicles built with NVIDIA technology, tying real-time in-car processing more tightly to cloud-based AI. See our latest analysis for Visteon. The NVIDIA partnership comes at a time when Visteon’s 1-year total shareholder return of 7.18% contrasts with a weaker 3-year total shareholder return, which shows a 44.07% decline. Recent 30 to 90 day share price returns also suggest that...
NYSE:SWX
NYSE:SWXGas Utilities

A Look At Southwest Gas Holdings (SWX) Valuation After Recent Share Price Weakness

Southwest Gas Holdings (SWX) has been drawing fresh attention after a period of mixed share performance, with a 3.1% decline over the past day and a 5.0% drop over the past week. See our latest analysis for Southwest Gas Holdings. While the share price has come under pressure recently, with a 3.1% 1 day share price decline and a 5.0% 7 day share price decline, the picture over longer periods has been more supportive. The stock has delivered a 4.3% year to date share price return alongside a...
OTCPK:FNMA
OTCPK:FNMADiversified Financial

Why Federal National Mortgage Association (FNMA) Is Down 13.1% After Expanded Federal MBS Support Shifted Investor Focus

In recent weeks, Fannie Mae and Freddie Mac have eased homeowners’ insurance and condo requirements while receiving federal direction to buy an additional US$200 billion of mortgage bonds, drawing renewed attention to their role in the housing-finance system. These policy shifts are prompting large asset managers to favor mortgage-backed securities as a perceived safer alternative to corporate debt during periods of market stress. We’ll now examine how this expanded federal support for...
NYSE:MTD
NYSE:MTDLife Sciences

Assessing Mettler-Toledo (MTD) Valuation After Recent Share Price Swings And Mixed Model Signals

Mettler-Toledo International (MTD) is back in focus after recent trading swings, with the share price moving higher over the past week but showing a decline over the month and over the past 3 months. See our latest analysis for Mettler-Toledo International. That pattern of a 2.62% 7 day share price return against a 12.56% 30 day decline suggests recent momentum is still fading, even though the 1 year total shareholder return is slightly positive at 0.44%. If you are looking beyond...
NYSE:IT
NYSE:ITIT

How Investors Are Reacting To Gartner (IT) Highlighting AI-Driven Renewal Trends In Its Research Platform

Earlier in March 2026, Meta Integration Technology, Inc. sponsored the Gartner Data & Analytics Summit in Orlando, showcasing its new MetaKarta Semantic Hub platform for unifying business semantics across databases, BI tools, and AI systems. Gartner’s leadership has also highlighted growing use of AI within its own research product, with early data indicating that users of its AskGartner tool exhibit materially higher subscription renewal rates, underscoring the potential revenue importance...
NYSE:AA
NYSE:AAMetals and Mining

Assessing Alcoa (AA) Valuation After Recent Share Price Pullback And 16% Undervaluation Narrative

Alcoa (AA) stock has been moving without a clear single headline, which puts the focus on its recent performance and fundamentals. The shares closed at $56.45, with mixed short term and longer term returns. See our latest analysis for Alcoa. The recent 3.75% 1 day and 11.23% 7 day share price declines sit against a softer 30 day share price return of a 6.68% decline, yet a 1 year total shareholder return of 68.14% suggests longer term momentum has been stronger than the latest pullback...
NasdaqGS:NXPI
NasdaqGS:NXPISemiconductor

NXP Targets Edge AI Growth With New Integrated i.MX 93W Processor

NXP Semiconductors (NasdaqGS:NXPI) has introduced the i.MX 93W applications processor, described as the first chip to pair a dedicated AI neural processing unit with secure tri radio wireless connectivity. The i.MX 93W is designed to cut system complexity and cost by consolidating up to 60 discrete components into a single, certified package for edge AI and IoT devices. The new system on chip targets use cases across healthcare, industrial controls, and smart infrastructure, with a focus on...
NYSE:KGS
NYSE:KGSEnergy Services

A Look At Kodiak Gas Services (KGS) Valuation After New Permian Compression Acquisition

Kodiak Gas Services (KGS) has expanded its Permian Basin footprint by acquiring more than 20,000 horsepower of large compression assets, paired with a seven-year service agreement that is expected to add over US$7 million in annualized revenue. See our latest analysis for Kodiak Gas Services. The latest acquisition comes as Kodiak’s share price sits at US$55.90, with a 1 month share price return of 10.41% and a 90 day share price return of 52.44%, while total shareholder return over the past...
NasdaqGS:TPG
NasdaqGS:TPGCapital Markets

Assessing TPG’s (TPG) Valuation As OpenAI Joint Venture Talks Take Shape

Why OpenAI’s proposed joint venture matters for TPG (NasdaqGS:TPG) Reports that OpenAI is in advanced talks with TPG to anchor a proposed US$10b joint venture give investors a fresh corporate event to consider when assessing the stock’s recent share performance. See our latest analysis for TPG. Despite the OpenAI joint venture talks, TPG’s recent share price performance has been weak, with a 30 day share price return of 9.98% and a year to date share price return of 39.06%. However, the 3...
NasdaqGS:FITB
NasdaqGS:FITBBanks

A Look At Fifth Third Bancorp (FITB) Valuation As Community And Digital Initiatives Gain Attention

Lima initiative and digital upgrades move to center stage Fifth Third Bancorp (FITB) is putting fresh attention on community investment and digital banking, selecting Lima, Ohio for a new Small Towns & Small Cities program while rolling out money management tools inside its mobile app. See our latest analysis for Fifth Third Bancorp. Recent headlines around Lima and the upgraded mobile app come as Fifth Third’s share price sits at US$44.19, with a 1 year total shareholder return of 16.01% and...
NYSE:FLG
NYSE:FLGBanks

Flagstar’s Senior Tech Hires to Advance S2 Digital Platform Might Change The Case For Investing In FLG

In March 2026, Flagstar Bank, N.A. appointed five senior technology leaders from firms including JPMorgan Chase, U.S. Bank, MUFG and Mastercard to accelerate its Simple and Sophisticated (S2) digital platform transformation for more than one million customers. The hires deepen Flagstar’s capabilities in cybersecurity, cloud infrastructure, artificial intelligence and product delivery, indicating a push to modernize how the bank designs, secures and scales its services. We’ll now examine how...
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

NVIDIA AWS Deal Highlights AI Growth Potential And Export Rule Risks

Nvidia (NasdaqGS:NVDA) and Amazon Web Services have agreed a multi year supply deal for more than one million Nvidia GPUs and related systems through 2027. The agreement covers several Nvidia architectures, networking gear and inference chips, deepening AWS reliance on Nvidia's AI stack. The deal comes as Nvidia faces heightened US scrutiny over its US$20b licensing agreement with AI startup Groq and past illegal chip exports to China via Super Micro Computer. Nvidia, through its GPU and...
NasdaqGS:MANH
NasdaqGS:MANHSoftware

A Look At Manhattan Associates (MANH) Valuation After New AI Supply Chain Win With Rainforest Distribution

Rainforest Distribution Corp.’s decision to implement Manhattan Associates (MANH) Active Supply Chain Planning puts fresh attention on the company’s AI driven, cloud native platform and its role in real time supply chain visibility. See our latest analysis for Manhattan Associates. Despite client wins like Rainforest Distribution, Manhattan Associates’ recent momentum has cooled, with a 30 day share price return showing a 4.8% decline and a 90 day share price return showing a 22% decline,...
NasdaqGS:FRSH
NasdaqGS:FRSHSoftware

The Bull Case For Freshworks (FRSH) Could Change Following New Buyback And AI Pricing Pivot – Learn Why

In February 2026, Freshworks authorized a US$400.0 million share repurchase program while holding US$844.0 million in cash and generating US$223.0 million in adjusted free cash flow for 2025, alongside increased insider buying by CEO Dennis Woodside. At the same time, Freshworks’ pivot from per-seat pricing to outcome-based AI models and its 2026 adjusted EPS guidance shortfall have raised fresh questions about how this new pricing approach may affect the company’s customer base and...
NasdaqCM:PLSE
NasdaqCM:PLSEMedical Equipment

Assessing Pulse Biosciences (PLSE) Valuation After The nPulse Cardiac Catheter Ablation Pivot

Pulse Biosciences (PLSE) has placed its nPulse Cardiac Catheter Ablation System at the center of its plans, following European feasibility data in Atrial Fibrillation and upcoming pivotal studies and conference presentations. See our latest analysis for Pulse Biosciences. These AFib data and the new focus on the nPulse Cardiac Catheter program come after a strong run, with a 90 day share price return of 45.39% and a very large 3 year total shareholder return. At the same time, the 1 year...
NasdaqGS:COLL
NasdaqGS:COLLPharmaceuticals

Collegium Pharmaceutical (COLL) Valuation Check After Recent Share Price Volatility

Collegium Pharmaceutical overview Collegium Pharmaceutical (COLL) has drawn attention after recent trading showed a 2.4% daily decline and a 21% drop over the past month, contrasting with a 17.9% total return over the past year. See our latest analysis for Collegium Pharmaceutical. The recent 21.2% 1 month share price decline, alongside a weaker 22.2% year to date share price return, contrasts with a stronger 17.9% 1 year total shareholder return. This suggests longer term holders have still...
NasdaqCM:SEZL
NasdaqCM:SEZLDiversified Financial

A Look At Sezzle (SEZL) Valuation After Auditor Change And Cash Flow Control Weakness

Sezzle (SEZL) has quickly moved into the spotlight after dismissing its independent auditor Baker Tilly, appointing PricewaterhouseCoopers for 2026, and disclosing a material weakness in cash flow classification controls. See our latest analysis for Sezzle. Despite the governance headlines, Sezzle’s share price has held near US$66.15, with a 5.42% 1 month share price return but an 11.98% 3 month share price decline. The 1 year total shareholder return of 68.23% points to strong longer term...
NYSE:ZGN
NYSE:ZGNLuxury

Does Margin Gains Amid Flat Sales Change The Bull Case For Ermenegildo Zegna (ZGN)?

Ermenegildo Zegna N.V. recently reported its full-year 2025 results, posting €1,916.95 million in sales versus €1,946.65 million a year earlier, while net income rose to €98.58 million and basic earnings per share from continuing operations increased to €0.38. Despite the slight revenue decline and sector headwinds, the company improved its gross margin, maintained positive free cash flow with a net cash surplus, and benefited from strong traction in its direct-to-consumer push and...
NYSE:SNX
NYSE:SNXElectronic

How Investors May Respond To TD SYNNEX (SNX) Strong Earnings And Expanded Public Sector Cybersecurity Push

Earlier in March 2026, BIO-key International announced a partnership with TD SYNNEX Public Sector (DLT Solutions) to distribute its PortalGuard IAM and Passkey:YOU biometric security tools across U.S. federal, state, and local government contracts. This move deepens TD SYNNEX’s reach in government-focused cybersecurity and identity management, aligning its distribution platform with compliance-heavy markets like CJIS, HIPAA, and NIST SP 800-171. We’ll now examine how TD SYNNEX’s...